Cheers TheDerivative for comments. CVA - cerebrovascular accident (stroke) at times has raised intracerebral pressures and raised sugar levels (ie. lends itself to Exanatide treatment). ADR is adverse drug reaction. CSF - cerebrospinal fluid.
Don't think i can confirm the $1.6B market cap. This is the orphan indication. The real value here is the other markets it lends itself to. ie. get it to market with IIH orphan indication - which would be the shortest path - but I see value in multiple other medical indications (mentioned above) which it would be an adjuvant therapy. Its market potential is a lot bigger then IIH. I'm struggling to see where this falls over. not sure on Corporate structure though I've done some due diligence on the heads - all
of which are incentivised with holdings.
Cheers TheDerivative for comments. CVA - cerebrovascular...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.335M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 28320 | 7.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.2¢ | 22452 | 2 |
View Market Depth
| Last trade - 16.12pm 06/09/2024 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable